CDC Website CDC Website

To Join the NPIN community or

Home » HIV Infection of the Central Nervous System (R01 Clinical Trial Not Allowed)

HIV Infection of the Central Nervous System (R01 Clinical Trial Not Allowed)

The goals of this Funding Opportunity Announcement (FOA) are to stimulate further research on delineating the pathophysiology of HIV-1 associated CNS disease in the setting of chronic viral suppression and ART. In addition, FOA also encourages research studies to aid in the identification/ validation of biomarkers and pre-clinical targets with quantifiable readouts in domestic and international settings. Multidisciplinary research teams and collaborative alliances are encouraged but not required.

Funding Organization
Funding Category
Support Types
Eligible Organizations
Number of Awards Given
Contingent upon NIH appropriations.
Award Amount Notes
Application budgets are not limited but need to reflect the actual needs of the proposed project.
Application Due Date
9/7/20
Project Start Date
4/1/21
Application Contact
Rita
Sisco
Lead/Supv Grants Management Specialist
301-443-2805
siscor@mail.nih.gov
Technical Contact
Jeymohan
Joseph, Ph.D.
Chief, HIV Neuropathogenesis, Genetics, and Therapeutics Branch
jjeymoha@mail.nih.gov
240-627-3869
Fund Duration
The scope of the proposed project should determine the project period. The maximum project period is 5 years.
Subjects
Audiences

Fund Number: 

346791

Fund ID: 

PA-20-149

Last modified: 

5/20/20